TA5 5mg*10vials

Thymosin α1 TA5 5mg x 10 Vials

Product Overview

Thymosin α1 TA5 is a high-purity immunomodulatory peptide in the immunopeptide category, serving as a classic foundational product in the thymosin α1 peptide series. This short-chain peptide is derived from a naturally occurring bioactive sequence from the thymus, exhibiting low immunogenicity and excellent biocompatibility. Thymosin α1 primarily regulates thymus-dependent immune cell development, balances innate and adaptive immune responses, and supports immune cell differentiation and maturation. The standardized 5mg dose provides stable immunomodulatory effects without overstimulating immune pathways. It is used in preclinical studies including immune remodeling, inflammation-immune imbalance models, host defense mechanism research, and peptide-based combined immunomodulation validation, serving as a core foundational research material in immunopharmacology and immune cell biology.

Core Research Functions

T Cell Maturation Promotion: Supports differentiation and maturation of T lymphocyte subsets.

Innate and Adaptive Immune Balance: Supports innate and adaptive immune homeostasis balancing.

Inflammatory Cytokine Regulation: Regulates inflammatory cytokine spectrum to alleviate immune-mediated inflammatory dysregulation.

Host Immune Defense Support: Supports host immune defense response under challenging conditions.

As a thymus-derived bioactive peptide, it supports immune cell functional state restoration under immunosuppression. It supports imbalanced cytokine secretion spectrum normalization and excessive or insufficient immune response phenotype mitigation. The 5mg baseline specification provides stable and reproducible biological response, suitable for long-term immune intervention studies, dose-reference experiments, and compound-peptide immune synergy studies, providing reliable baseline experimental data for immunophysiology, immunopathology, and related preclinical studies.

Key Advantages

Thymus-Derived Immune Regulation Mechanism: The bioactive sequence mimics endogenous thymus-derived peptides, acting on the T cell maturation pathway to achieve physiologically guided immune homeostasis regulation rather than simple immune stimulation.

Bidirectional Immune Homeostasis Regulation: Simultaneously regulates innate and adaptive immunity, supporting immune bias correction under immunosuppression or inflammatory imbalance conditions.

Broad Preclinical Research Compatibility: Suitable for single-drug mechanism exploration and peptide-based immunomodulatory studies, widely applicable to immunology-related cell and animal model research.

Rigorous Purification and Lyophilization Process: Employs multi-level gradient purification combined with vacuum lyophilization, preserving molecular activity with low background contaminants, ensuring stability and reproducibility of experimental results.

Standard Aseptic Packaging: 10 vials per dust-free aseptic package. Each batch undergoes high-performance liquid chromatography (HPLC) purity testing and is accompanied by a complete Certificate of Analysis (COA). With long-term stable activity, it is suitable for academic laboratory projects and bulk purchases.

Specifications and Quality Control

Format: Lyophilized powder, 5mg per vial. Packaging: 10 vials per pack, dust-free aseptic integrated container. Purity Testing: Full HPLC purity verification with complete Certificate of Analysis (COA).